Medications not yet evaluated by P&T are considered NON-FORMULARY. Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step!
Please be sure to document all clinical activities daily.
Search results for:

darunavir-cobicistat-emtricitabine-tenofovir alafenamide

darunavir-cobicistat-emtricitabine-tenofovir alafenamide
  • Formulary
Drug Name Form Strength Formulary Unrestricted Formulary Restricted Non-Formulary Interchange
Symtuza TABLET, ORAL 800 mg-150 mg-200 mg-10 mg      
Comments:

Symtuza is formulary unrestricted. Inpatients are encouraged to use home supply. Symtuza may be obtained if patient's home supply is unavailable. Defer initiation to outpatient.

Reviewed: 27 Nov 2018 (Symtuza)

Last updated: Mar. 25, 2019






This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.

Copyright © 2026 Rpharmy, LLC ­ All Rights Reserved